drugset / Trial / NCT03985384
Semaglutide Treatment On Coronary Progression
Phase 4
Completed
140 enrolled
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to see the effect of the diabetes medicine Semaglutide on a condition called atherosclerosis. Atherosclerosis is a narrowing, blockage, or hardening of the arteries due to a build up of calcium. This study will look specifically at the arteries involving the heart.
Timeline
- Start
- 2019-04-30
- Primary completion
- 2022-12-27
- Completion
- 2022-12-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Semaglutide | Peptide | 2 mg | Subcutaneous |